▲ Peaking
Business
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad approval for Gilead’s Trodelvy to treat first-line triple-negative breast cancer, signaling a shift in standard care protocols.
Gilead
2 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Health
🔮 holds
US provides Ebola treatment for outbreak in Congo, bringing trials closer
Experimental Ebola treatments are headed to the Democratic Republic of Congo for imminent clinical trials following U.S. intervention.